Charles River Laboratories International (CRL) announced on Wednesday a strategic review of its business and prospects, "including an examination of various alternatives to enhance long-term ...

Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value May 07, 2025 7:00 AM ET Charles River Laboratories International, Inc. (CRL) Q1 ...

Charles River Laboratories stock surged 16% Wednesday morning as the medical testing company made changes to its board and announced a strategic review as it faced pressure from Elliott Investment ...

Charles River Laboratories’ shares declined 28% on April 10 following the US Food and Drug Administration’s announcement to reduce reliance on animal testing for drug development, in favor of ...

Charles River also announced a Cooperation Agreement with Elliott Investment Management L.P., Charles River’s largest investor, under which Elliott has agreed to customary standstill, voting ...